ProstateProstate-Specific AntigenProstatic NeoplasmsProstatic HyperplasiaAndrogensReceptors, AndrogenProstatectomyAndrogen AntagonistsCell Line, TumorTransurethral Resection of ProstateOrchiectomyProstatic Intraepithelial NeoplasiaAdenocarcinomaNeoplasms, Hormone-DependentGene Expression Regulation, NeoplasticProstatic DiseasesDihydrotestosteroneTumor Markers, BiologicalTosyl CompoundsDigital Rectal ExaminationFinasterideDisease ProgressionMice, NudeTumor Cells, CulturedBone NeoplasmsCell ProliferationNeoplasm GradingAndrogen Receptor AntagonistsProstatitisApoptosisImmunohistochemistryBrachytherapyNeoplasm Metastasis5-alpha Reductase InhibitorsSeminal VesiclesAnilidesNeoplasm StagingCastrationWatchful WaitingFlutamideTestosteroneAntineoplastic Agents, HormonalCase-Control StudiesMetriboloneBiopsy, NeedleReverse Transcriptase Polymerase Chain ReactionBiopsyAzasteroidsRNA, MessengerGlutamate Carboxypeptidase IINeoplasm TransplantationRisk FactorsAntineoplastic AgentsNeoplasm InvasivenessTransplantation, HeterologousXenograft Model Antitumor AssaysSignal Transduction3-Oxo-5-alpha-Steroid 4-DehydrogenaseProstatic Neoplasms, Castration-ResistantCholestenone 5 alpha-ReductaseEpithelial CellsNeoplasm ProteinsTestosterone CongenersPrognosisPTEN PhosphohydrolaseAndrogen-Binding ProteinBlotting, WesternGenetic Predisposition to DiseaseRadiotherapy, ConformalCarcinomaCell Growth ProcessesSensitivity and SpecificityProstatic Secretory ProteinsCell DivisionAnticarcinogenic AgentsRacemases and EpimerasesRectumTime FactorsTreatment OutcomeMice, SCIDGene Expression ProfilingCohort StudiesDown-RegulationRadiotherapy Planning, Computer-AssistedRadiotherapy, Intensity-ModulatedEstramustineAndrostenolsMass ScreeningTaxoidsEarly Detection of CancerNeoplasm Recurrence, LocalPhenylthiohydantoinRadiotherapy DosageOrgan SizeIncidenceGene FusionRNA, Small InterferingTransfectionRadiotherapy, Image-GuidedCell Survival